Provided by Tiger Trade Technology Pte. Ltd.

Dolby Laboratories

57.47
-1.2700-2.16%
Post-market: 57.470.00000.00%17:17 EDT
Volume:794.53K
Turnover:45.99M
Market Cap:5.38B
PE:24.47
High:59.21
Open:59.21
Low:57.43
Close:58.74
52wk High:73.01
52wk Low:48.26
Shares:93.67M
Float Shares:58.75M
Volume Ratio:0.74
T/O Rate:1.35%
Dividend:1.44
Dividend Rate:2.51%
EPS(TTM):2.35
EPS(LYR):2.62
ROE:8.76%
ROA:5.15%
PB:2.08
PE(LYR):21.94

Loading ...

Fau Video Compression Technology Portfolio Acquired by Dolby Laboratories

THOMSON REUTERS
·
Aug 11

Press Release: CervoMed Reports Second Quarter 2026 Financial Results and Provides Corporate Updates

Dow Jones
·
Aug 10

Dolby SVP Entertainment John D. Couling Disposes of 7,667 Common Shares for $460,454.42

Reuters
·
Aug 06

Dolby (DLB) Stock Price Races Ahead Of Falling Profit```

Simply Wall St.
·
Aug 01

Dolby Laboratories up over 12%, on Track for Largest Percent Increase Since November 2024

Dow Jones
·
Aug 01

Dolby Laboratories Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Jul 31

Analysts’ Top Industrial Goods Picks: TriNet Group (TNET), Dolby Laboratories (DLB)

TIPRANKS
·
Jul 31

Dolby FY26 Q3 GAAP Net Income Drops to USD 29 Million; Revenue Slips to USD 305 Million

Reuters
·
Jul 31

Dolby Laboratories Q3 Adj. EPS $0.69 Beats $0.67 Estimate, Sales $304.995M Miss $311.960M Estimate

Benzinga Earnings
·
Jul 31

Dolby Laboratories Q3 Revenue USD 305 Million Vs. IBES Estimate USD 312 Million

Reuters
·
Jul 31

Dolby Laboratories Reports Third Quarter 2026 Financial Results

THOMSON REUTERS
·
Jul 31

Dolby Laboratories - Board Approves Increasing Stock Repurchase Program by $350 Mln to $427 Mln

THOMSON REUTERS
·
Jul 31

Dolby Laboratories Q3 Dividend USD 0.36

THOMSON REUTERS
·
Jul 31

Earning Preview: Dolby Laboratories this quarter’s revenue is expected to increase by 2.20%, and institutional views are bullish

Earnings Agent
·
Jul 24

Dolby (DLB) Stock Looks Reasonable On Earnings While Returns Stay Weak

Simply Wall St.
·
Jul 19

CervoMed advances neflamapimod strategy with new DLB data

TIPRANKS
·
Jul 15

Dolby Sets Conference Call, Webcast for Q3 Fiscal 2026 Results

Reuters
·
Jul 15

Dolby Laboratories (DLB) Gets a Buy from Barrington

TIPRANKS
·
Jul 14

CervoMed’s DLB Trial Milestone: What CRVO Investors Should Watch Next

TIPRANKS
·
Jul 09

Dolby SVP Entertainment John D. Couling Disposes of 7,667 Common Shares for $407,951.37

Reuters
·
Jul 07